miRoncol was founded with a clear vision: to make meaningful early cancer risk assessment accessible to individuals and healthcare professionals who value prevention and early detection.
Our Real-time Multi-Cancer Early Risk Assessment uses microRNA biomarkers and AI-based analysis to detect biological signals consistent with early cancer providing a new layer of clarity in cancer prevention and early detection.
To take proactive steps in their health journey.
With science-backed tools that complement clinical practice.
By bringing real-time molecular insights into everyday health checkups.
Behind miRoncol is a multidisciplinary team of leaders in oncology, molecular biology, data science, and health innovation. Together, we are committed to turning cutting-edge research into tools that are accurate, affordable, and accessible.
Scientific rigor is at the core of what we do. Our approach is built on:
Learn more about who we are and why we’re committed to transforming cancer prevention.